1-(carboxymethylthio)tetradecane has been researched along with Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aakvaag, A; Abdi-Dezfuli, F; Berge, RK; Frøyland, L; Thorsen, T | 1 |
| Abdi-Dezfuli, F; Berge, K; Berge, RK; Bjerkvig, R; Mahesparan, R; Ranheim, T; Tronstad, KJ | 1 |
2 other study(ies) available for 1-(carboxymethylthio)tetradecane and Breast Cancer
| Article | Year |
|---|---|
Eicosapentaenoic acid and sulphur substituted fatty acid analogues inhibit the proliferation of human breast cancer cells in culture.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antioxidants; Arachidonic Acid; Breast Neoplasms; Buthionine Sulfoximine; Cell Division; Drug Interactions; Eicosapentaenoic Acid; Fatty Acids; Glutathione; Humans; Oxidants; Oxidation-Reduction; Oxidative Stress; Sulfides; Sulfur Compounds; Tumor Cells, Cultured | 1997 |
Poorly oxidizable fatty acid analogues inhibit the proliferation of cancer cells in culture.
Topics: Animals; Breast Neoplasms; Cell Division; Colonic Neoplasms; Docosahexaenoic Acids; Eicosapentaenoic Acid; Female; Glioma; HL-60 Cells; Humans; Male; Rats; Sulfides; Tumor Cells, Cultured | 1999 |